Bicara Therapeutics BCAX Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's increase (decrease) in prepaid expense and other assets?
- Bicara Therapeutics (BCAX) reported increase (decrease) in prepaid expense and other assets of -$2.09M in Q1 2026.
- How has Bicara Therapeutics's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Bicara Therapeutics's increase (decrease) in prepaid expense and other assets increased by 49.2% year-over-year, from -$4.12M to -$2.09M.
- What does increase (decrease) in prepaid expense and other assets mean?
- Represents the net change in prepaid expenses and other current assets during the reporting period. This metric reflects cash outflows for services or goods to be received in the future, providing insight into working capital management and near-term operational commitments.